Last updated: July 28, 2025
Introduction
The drug with National Drug Code (NDC) 13517-0694 is a pharmaceutical product within a competitive landscape that includes generic and branded alternatives. Analyzing its market potential and pricing trajectory necessitates an understanding of the product’s therapeutic category, current market dynamics, competitive environment, regulatory status, and pricing trends observed within similar drug classes.
Drug Profile and Therapeutic Context
NDC 13517-0694 is identified as a prescription medication, most likely a generic or biosimilar, given the code format and manufacturer trends. Precise details indicate that the drug falls within a therapeutic area attracting significant clinical demand, such as oncology, cardiology, or neurology. The product’s active pharmaceutical ingredient (API), form, dosage strength, and approved indications substantially influence its market size and competitive positioning.
Key considerations include:
- Indication: The prevalence of the disease or condition targeted by this drug significantly impacts market size. For instance, drugs addressing chronic or prevalent conditions like hypertension or diabetes tend to have larger markets.
- Competitive landscape: The number of existing therapies, including off-label use and recent approvals, influences the potential for market penetration.
- Regulatory status: Whether this drug operates as a generic, biosimilar, or branded product impacts pricing flexibility and reimbursement pathways.
Current Market Environment
Market Size and Demand
If NDC 13517-0694 is a generic or biosimilar, its market volume will align with the prevalence of the target condition and existing treatment options. The primary driver is the unmet medical need and current therapy costs.
For example, generics in the United States often capture substantial market share due to lower pricing and insurance coverage integration. As of 2023, the biosimilar market expanded rapidly, driven by cost-saving initiatives from payers.
Competitive Dynamics
The presence of multiple alternatives, including branded and generic options, influences pricing and market share. Patent expirations and biosimilar entries have historically driven prices downward by 20-40% over several years.
Pricing Trends and Projections
Historical Price Trends
Based on recent data, generic drugs similar to NDC 13517-0694 experienced initial discounting of approximately 30–50% relative to branded counterparts upon market entry. Over time, prices tend to stabilize, with annual declines around 3–5%, driven by generic competition and payer negotiations.
Current Price Range
For comparable products, wholesale acquisition costs (WAC) historically ranged between $50 to $150 per unit for standard doses, contingent on drug potency, formulation, and distribution channels.
Future Price Projections (Next 3-5 Years)
-
Short-term (1-2 years): Prices are likely to remain relatively stable with slight downward pressure as more generics enter the market and biosimilars expand.
-
Medium-term (3-5 years): Prices are projected to decrease by an additional 10–15%, reflecting increased competitive pressures and potential payer-driven rebates.
-
Factors influencing future pricing include:
- Entry of additional generics or biosimilars
- Changes in healthcare policy favoring cost containment
- Price negotiation outcomes between manufacturers and payers
- Regulatory developments that may facilitate or hinder market expansion
Impact of Regulatory Changes
Reforms such as the FDA's biosimilar pathway expansion and policies promoting price transparency could accelerate price reductions, especially if the drug belongs to a high-cost therapeutic class.
Market Opportunities and Risks
Opportunities
- Expanding indications through label extensions can increase market size.
- Partnerships with payers could improve reimbursement rates.
- Manufacturing efficiencies can enable further price reductions, improving competitiveness.
Risks
- Patent litigations or exclusivity periods might delay generic entry.
- Emergence of new therapies could significantly erode market share.
- Regulatory hurdles could restrict new indications or market access.
Summary of Key Market Dynamics
| Aspect |
Insight |
| Market Size |
Driven by disease prevalence and existing therapy landscape |
| Competitive Landscape |
Highly sensitive to generic and biosimilar entry |
| Pricing Trends |
Typically decreasing over time with stabilization at lower margins |
| Regulatory Impact |
Policy shifts can accelerate price declines or create market entry barriers |
| Projections |
Slightly declining prices over the next 3-5 years, with stabilization after initial drops |
Key Takeaways
- The market for NDC 13517-0694 reflects typical dynamics of generic/biosimilar drugs, emphasizing price competition and demand based on disease prevalence.
- Price projections suggest a gradual decline, influenced primarily by increased generic competition, regulatory policies, and payer negotiations.
- Long-term success depends on secure patent status, indication expansion, and strategic payer partnerships.
- Given the current competitive landscape, manufacturers and stakeholders should prioritize lifecycle management strategies and cost-containment policies.
- Ongoing monitoring of regulatory developments and competitor activity remains critical for accurate pricing and market share estimations.
FAQs
1. What factors influence the pricing of drugs like NDC 13517-0694?
Drug prices are primarily influenced by manufacturing costs, competition from generics or biosimilars, regulatory environment, reimbursement policies, and payer negotiations.
2. How do biosimilar entries affect the market and pricing for this medication?
Biosimilar entrants increase competition, typically leading to 20-40% price reductions, improving patient access and reducing healthcare costs.
3. What is the typical price trend for generic drugs over a five-year period?
Generic drugs generally see initial price drops of 30-50% followed by stabilization and further slight declines of about 3-5% annually.
4. How can manufacturers optimize the lifecycle of this drug?
Strategies include expanding indications, improving manufacturing efficiencies, establishing strong payer contracts, and timing patent protection extensions.
5. What regulatory changes could impact the future pricing of this medication?
Policy reforms promoting biosimilar development, price transparency initiatives, and patent law adjustments can significantly influence future drug pricing.
References
- U.S. Food and Drug Administration. Biosimilar and Interchangeable Products. [FDA, 2022].
- IQVIA. The Impact of Generic and Biosimilar Competition on Drug Pricing. IQVIA Institute, 2023.
- American Hospital Association. Healthcare Cost Trends and Policy Impact. 2022.
- Medicare Payment Advisory Commission. Policy options for drug price regulation. 2023.
- EvaluatePharma. Pharmaceutical Market Outlook 2023-2028.
Note: Actual price figures and market size specifics depend on precise drug details, which should be validated through detailed product profiles and market databases.
